AMPD1 genotypes and exercise capacity in McArdle patients

Gespeichert in:
Bibliographische Detailangaben
Deutscher übersetzter Titel:AMPD1 Genotypus und Trainingskapazität bei Patienten mit McArdle-Syndrom
Autor:Rubio, J.C.; Pérez, M.; Maté-Muñoz, J.L.; Garcia-Consuegra, I.; Arenas, J.; Valle, Maria Fernández del; Andreu, A.L.; Martin, A.M.; Lucia, A.; Chamorro-Viña, Carolina
Erschienen in:International journal of sports medicine
Veröffentlicht:29 (2008), 4, S. 331-335, Lit.
Format: Literatur (SPOLIT)
Publikationstyp: Zeitschriftenartikel
Medienart: Gedruckte Ressource Elektronische Ressource (online)
Sprache:Englisch
ISSN:0172-4622, 1439-3964
DOI:10.1055/s-2007-965358
Schlagworte:
Online Zugang:
Erfassungsnummer:PU200809002825
Quelle:BISp

Abstract

The purpose of this study was to assess if there exists an association between C34T muscle adenosine monophosphate deaminase (AMPD1) genotypes (i.e., normal homyzygotes [CC] vs. heterozygotes [CT]) and directly measured indices of exercise capacity (peak oxygen uptake [VO2peak], ventilatory threshold [VT], gross mechanical efficiency [GE], etc.) in 44 Caucasian McArdle patients (23 males, 21 females). All patients performed a graded cycle ergometer test until exhaustion (for VO2peak and VT determination) and a 12-min constant-load test at the power output eliciting the VT (for GE determination). We found no significant difference in indices of exercise capacity between CC (n = 18) and CT genotypes (n = 5) in the group of male patients (p > 0.05). In contrast, the VO2 at the VT was significantly lower (p < 0.05) in CT (n = 4; 7.9 +/- 0.4 ml/kg/min) than in CC female patients (n = 17; 11.0 +/- 0.9 ml/kg/min). In summary, heterozigosity for the C34T allele of the AMPD gene is associated with reduced submaximal aerobic capacity in female patients with McArdle disease and might partly account, in this gender, for the variability that exists in the phenotypic manifestation of the disease. Verf.-Referat